Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CTS CORPCTS · Entity 4654 | Director | November 06, 2025 | November 10, 2025 |
| PROCEPT BioRobotics CorpPRCT · Entity 4831 | Director | June 09, 2026 | June 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CTS CORP
Report date November 06, 2025 · Filed November 10, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,800 |
Reported balance
After 2025-11-06 transaction · row 1
1 source rowRow 1 · 2025-11-06 · Grant · Acquired 3,500 · Balance 8,800 F1: Restricted stock units vest 100% on the first anniversary of the grant date, contingent upon the recipient's continued service as a director through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units vest 100% on the first anniversary of the grant date, contingent upon the recipient's continued service as a director through the vesting date.
PROCEPT BioRobotics Corp
Report date June 09, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,941 |
Reported balance
After 2026-06-09 transaction · row 1
1 source rowRow 1 · 2026-06-09 · Grant · Acquired 3,315 · Balance 10,941 F1: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.78 · Expires 2036-06-08 | Direct | 5,853 |
Reported balance
After 2026-06-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-09 · Grant · Acquired 5,853 · Balance 5,853 F2: The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
F2: The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Hill-Rom Holdings, Inc.
Report date December 13, 2021 · Filed December 15, 2021
Section 16 reporting ended · disclosed 2021-12-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 1
1 source rowRow 1 · 2021-12-13 · Disposition to issuer · Disposed 3,903.0663 · Balance 0 F1: Amount of securities beneficially owned at the end of the reporting period includes 110.0663 shares held in the Hill-Rom Holdings, Inc. Employee Stock Purchase Plan. F2: Disposed of pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter (the "Merger Agreement") in exchange for a cash payment of $156.00 per share of common stock. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.70 · Expires 2026-11-14 | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-12-13 · Disposition to issuer · Disposed 302 · Balance 0 F3: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 4, 2017, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $78.16 · Expires 2027-11-08 | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-12-13 · Disposition to issuer · Disposed 1,032 · Balance 0 F4: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 8, 2018, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $103.11 · Expires 2029-11-06 | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-12-13 · Disposition to issuer · Disposed 5,992 · Balance 0 F5: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 6, 2020, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $94.14 · Expires 2030-11-11 | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-12-13 · Disposition to issuer · Disposed 9,513 · Balance 0 F6: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 11, 2021, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock. |
| Performance-Based Restricted Stock Units (11/06/2019)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-12-13 · Disposition to issuer · Disposed 2,883 · Balance 0 F7: Each performance-based restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F8: Pursuant to the Merger Agreement, these performance-based restricted stock units, which were granted November 6, 2019, were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock and applicable performance conditions were deemed to be achieved at 146.0% of the target performance level. |
| Performance-Based Restricted Stock Units (11/11/2020)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-12-13 · Disposition to issuer · Disposed 4,822 · Balance 0 F7: Each performance-based restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F9: Pursuant to the Merger Agreement, these performance-based restricted stock units, which were granted November 11, 2020, were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock and applicable performance conditions were deemed to be achieved at 187.5% of the target performance level. |
| Restricted Stock Units (11/06/2019)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2021-12-13 · Disposition to issuer · Disposed 485 · Balance 0 F10: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F11: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 7, 2020, were cancelled in exchange for a cash payment of $156.00 per unvested share of underlying common stock. |
| Restricted Stock Units (11/11/2020)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2021-12-13 · Disposition to issuer · Disposed 1,606 · Balance 0 F10: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F12: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 12, 2021, were cancelled in exchange for a cash payment of $156.00 per unvested share of underlying common stock. |
| Restricted Stock Units (11/10/2021)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2021-12-13 · Disposition to issuer · Disposed 7,032 · Balance 0 F10: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F13: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 11, 2022, were assumed by Baxter in the merger and converted into a number of restricted stock units granted by Baxter, that relate to shares of Baxter common stock, determined by multiplying the number of restricted stock units by the quotient obtained by dividing (A) 156.00 by (B) the average closing price, rounded down to the nearest cent, per share of Hill-Rom Holdings, Inc. common stock on the New York Stock Exchange for the consecutive period of ten (10) trading days immediately preceding (but not including) the last trading day prior to the closing date of the merger. |
Filing footnotes · ownership attribution and instrument terms
F1: Amount of securities beneficially owned at the end of the reporting period includes 110.0663 shares held in the Hill-Rom Holdings, Inc. Employee Stock Purchase Plan.
F2: Disposed of pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter (the "Merger Agreement") in exchange for a cash payment of $156.00 per share of common stock.
F3: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 4, 2017, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock.
F4: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 8, 2018, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock.
F5: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 6, 2020, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock.
F6: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 11, 2021, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock.
F7: Each performance-based restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock.
F8: Pursuant to the Merger Agreement, these performance-based restricted stock units, which were granted November 6, 2019, were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock and applicable performance conditions were deemed to be achieved at 146.0% of the target performance level.
F9: Pursuant to the Merger Agreement, these performance-based restricted stock units, which were granted November 11, 2020, were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock and applicable performance conditions were deemed to be achieved at 187.5% of the target performance level.
F10: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock.
F11: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 7, 2020, were cancelled in exchange for a cash payment of $156.00 per unvested share of underlying common stock.
F12: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 12, 2021, were cancelled in exchange for a cash payment of $156.00 per unvested share of underlying common stock.
F13: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 11, 2022, were assumed by Baxter in the merger and converted into a number of restricted stock units granted by Baxter, that relate to shares of Baxter common stock, determined by multiplying the number of restricted stock units by the quotient obtained by dividing (A) 156.00 by (B) the average closing price, rounded down to the nearest cent, per share of Hill-Rom Holdings, Inc. common stock on the New York Stock Exchange for the consecutive period of ten (10) trading days immediately preceding (but not including) the last trading day prior to the closing date of the merger.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2026 Filed Jun 10, 2026 20:45 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantStock Option (Right to Buy) · Derivative | 5,853 | $0.00 Strike: $28.78 | $0.00 |
DisclosureSEC source: 0001628280-26-042273 · wk-form4_1781124298.xml · derivative · entry 2 Dodrill Amy M. · CIK 0001778116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,853 Underlying: Common Stock · 5,853 shares Expires 2036-06-08 F2 · derivative.exercise_date: The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 20:45 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 3,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-042273 · wk-form4_1781124298.xml · nonDerivative · entry 1 Dodrill Amy M. · CIK 0001778116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,941 F1 · kind: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| November 06, 2025 Filed Nov 10, 2025 21:04 UTC | CTS CORP CTS · Entity 4654 | GrantCommon Stock | 3,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000026058-25-000020 · form4.xml · nonDerivative · entry 1 Dodrill Amy M. · CIK 0001778116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,800 F1 · shares: Restricted stock units vest 100% on the first anniversary of the grant date, contingent upon the recipient's continued service as a director through the vesting date. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:21 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantStock Option (Right to Buy) · Derivative | 2,771 | $0.00 Strike: $64.23 | $0.00 |
DisclosureSEC source: 0001628280-25-030971 · wk-form4_1749759670.xml · derivative · entry 2 Dodrill Amy M. · CIK 0001778116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,771 Underlying: Common Stock · 2,771 shares Expires 2035-06-09 F2 · derivative.exercise_date: The Stock option was granted on June 10, 2025 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:21 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 1,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-030971 · wk-form4_1749759670.xml · nonDerivative · entry 1 Dodrill Amy M. · CIK 0001778116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,626 F1 · kind: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 21:09 UTC | CTS CORP CTS · Entity 4654 | GrantCommon Stock | 2,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-124079 · ownership.xml · nonDerivative · entry 1 Dodrill Amy M. · CIK 0001778116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,300 F1 · shares: Time based RSUs generally vesting on the first anniversary of the grant date. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:31 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantStock Option (Right to Buy) · Derivative | 2,526 | $0.00 Strike: $67.29 | $0.00 |
DisclosureSEC source: 0001628280-24-027057 · wk-form4_1717705873.xml · derivative · entry 2 Dodrill Amy M. · CIK 0001778116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,526 Underlying: Common Stock · 2,526 shares Expires 2034-06-03 F2 · derivative.exercise_date: The Stock Option was granted on June 4, 2024 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:31 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 1,376 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-027057 · wk-form4_1717705873.xml · nonDerivative · entry 1 Dodrill Amy M. · CIK 0001778116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,088 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| February 08, 2024 Filed Feb 9, 2024 21:58 UTC | CTS CORP CTS · Entity 4654 | GrantCommon Stock | 2,900 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-013356 · ownership.xml · nonDerivative · entry 1 Dodrill Amy M. · CIK 0001778116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,900 F1 · shares: Time-based RSUs vesting on November 2, 2024. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:50 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantStock Option (Right to Buy) · Derivative | 4,865 | $0.00 Strike: $35.09 | $0.00 |
DisclosureSEC source: 0001628280-23-022500 · wk-form4_1686948639.xml · derivative · entry 2 Dodrill Amy M. · CIK 0001778116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,865 Underlying: Common Stock · 4,865 shares Expires 2033-06-14 F2 · derivative.exercise_date: The Stock Option was granted on June 15, 2023 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:50 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 2,711 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-022500 · wk-form4_1686948639.xml · nonDerivative · entry 1 Dodrill Amy M. · CIK 0001778116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,712 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:16 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock · Derivative | 4,205 | $0.00 Strike: $38.85 | $0.00 |
DisclosureSEC source: 0001628280-22-016692 · wf-form4_165480576667666.xml · derivative · entry 2 Dodrill Amy M. · CIK 0001778116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,205 Underlying: Common Stock · 4,205 shares Expires 2032-06-06 F2 · price: The Stock option was granted on June 7, 2022 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. F2 · derivative.exercise_date: The Stock option was granted on June 7, 2022 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:16 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 2,001 | $37.48 | $74,997.48 |
DisclosureSEC source: 0001628280-22-016692 · wf-form4_165480576667666.xml · nonDerivative · entry 1 Dodrill Amy M. · CIK 0001778116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,001 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 20:40 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Disposition to issuerRestricted Stock Units (11/10/2021) · Derivative | 7,032 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-21-013215 · marketforms-54650.xml · derivative · entry 10 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,032 shares Expires not disclosed F10 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F13 · price: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 11, 2022, were assumed by Baxter in the merger and converted into a number of restricted stock units granted by Baxter, that relate to shares of Baxter common stock, determined by multiplying the number of restricted stock units by the quotient obtained by dividing (A) 156.00 by (B) the average closing price, rounded down to the nearest cent, per share of Hill-Rom Holdings, Inc. common stock on the New York Stock Exchange for the consecutive period of ten (10) trading days immediately preceding (but not including) the last trading day prior to the closing date of the merger. F13 · derivative.exercise_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 11, 2022, were assumed by Baxter in the merger and converted into a number of restricted stock units granted by Baxter, that relate to shares of Baxter common stock, determined by multiplying the number of restricted stock units by the quotient obtained by dividing (A) 156.00 by (B) the average closing price, rounded down to the nearest cent, per share of Hill-Rom Holdings, Inc. common stock on the New York Stock Exchange for the consecutive period of ten (10) trading days immediately preceding (but not including) the last trading day prior to the closing date of the merger. F13 · derivative.expiration_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 11, 2022, were assumed by Baxter in the merger and converted into a number of restricted stock units granted by Baxter, that relate to shares of Baxter common stock, determined by multiplying the number of restricted stock units by the quotient obtained by dividing (A) 156.00 by (B) the average closing price, rounded down to the nearest cent, per share of Hill-Rom Holdings, Inc. common stock on the New York Stock Exchange for the consecutive period of ten (10) trading days immediately preceding (but not including) the last trading day prior to the closing date of the merger. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 20:40 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Disposition to issuerRestricted Stock Units (11/11/2020) · Derivative | 1,606 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-21-013215 · marketforms-54650.xml · derivative · entry 9 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,606 shares Expires not disclosed F10 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F12 · price: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 12, 2021, were cancelled in exchange for a cash payment of $156.00 per unvested share of underlying common stock. F12 · derivative.exercise_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 12, 2021, were cancelled in exchange for a cash payment of $156.00 per unvested share of underlying common stock. F12 · derivative.expiration_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 12, 2021, were cancelled in exchange for a cash payment of $156.00 per unvested share of underlying common stock. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 20:40 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Disposition to issuerRestricted Stock Units (11/06/2019) · Derivative | 485 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-21-013215 · marketforms-54650.xml · derivative · entry 8 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 485 shares Expires not disclosed F10 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F11 · price: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 7, 2020, were cancelled in exchange for a cash payment of $156.00 per unvested share of underlying common stock. F11 · derivative.exercise_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 7, 2020, were cancelled in exchange for a cash payment of $156.00 per unvested share of underlying common stock. F11 · derivative.expiration_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 7, 2020, were cancelled in exchange for a cash payment of $156.00 per unvested share of underlying common stock. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 20:40 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Disposition to issuerPerformance-Based Restricted Stock Units (11/11/2020) · Derivative | 4,822 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-21-013215 · marketforms-54650.xml · derivative · entry 7 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,822 shares Expires not disclosed F7 · derivative.exercise_price: Each performance-based restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F9 · price: Pursuant to the Merger Agreement, these performance-based restricted stock units, which were granted November 11, 2020, were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock and applicable performance conditions were deemed to be achieved at 187.5% of the target performance level. F9 · derivative.exercise_date: Pursuant to the Merger Agreement, these performance-based restricted stock units, which were granted November 11, 2020, were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock and applicable performance conditions were deemed to be achieved at 187.5% of the target performance level. F9 · derivative.expiration_date: Pursuant to the Merger Agreement, these performance-based restricted stock units, which were granted November 11, 2020, were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock and applicable performance conditions were deemed to be achieved at 187.5% of the target performance level. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 20:40 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Disposition to issuerPerformance-Based Restricted Stock Units (11/06/2019) · Derivative | 2,883 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-21-013215 · marketforms-54650.xml · derivative · entry 6 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,883 shares Expires not disclosed F7 · derivative.exercise_price: Each performance-based restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F8 · price: Pursuant to the Merger Agreement, these performance-based restricted stock units, which were granted November 6, 2019, were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock and applicable performance conditions were deemed to be achieved at 146.0% of the target performance level. F8 · derivative.exercise_date: Pursuant to the Merger Agreement, these performance-based restricted stock units, which were granted November 6, 2019, were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock and applicable performance conditions were deemed to be achieved at 146.0% of the target performance level. F8 · derivative.expiration_date: Pursuant to the Merger Agreement, these performance-based restricted stock units, which were granted November 6, 2019, were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock and applicable performance conditions were deemed to be achieved at 146.0% of the target performance level. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 20:40 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 9,513 | $61.86 Strike: $94.14 | $588,474.18 |
DisclosureSEC source: 0001214659-21-013215 · marketforms-54650.xml · derivative · entry 5 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,513 shares Expires 2030-11-11 F6 · price: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 11, 2021, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock. F6 · derivative.exercise_date: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 11, 2021, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 20:40 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 5,992 | $52.89 Strike: $103.11 | $316,916.88 |
DisclosureSEC source: 0001214659-21-013215 · marketforms-54650.xml · derivative · entry 4 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,992 shares Expires 2029-11-06 F5 · price: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 6, 2020, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock. F5 · derivative.exercise_date: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 6, 2020, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 20:40 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 1,032 | $77.84 Strike: $78.16 | $80,330.88 |
DisclosureSEC source: 0001214659-21-013215 · marketforms-54650.xml · derivative · entry 3 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,032 shares Expires 2027-11-08 F4 · price: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 8, 2018, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock. F4 · derivative.exercise_date: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 8, 2018, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 20:40 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 302 | $102.30 Strike: $53.70 | $30,894.60 |
DisclosureSEC source: 0001214659-21-013215 · marketforms-54650.xml · derivative · entry 2 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 302 shares Expires 2026-11-14 F3 · price: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 4, 2017, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 4, 2017, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 20:40 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Disposition to issuerCommon Stock | 3,903.0663 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-21-013215 · marketforms-54650.xml · nonDerivative · entry 1 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Amount of securities beneficially owned at the end of the reporting period includes 110.0663 shares held in the Hill-Rom Holdings, Inc. Employee Stock Purchase Plan. F2 · price: Disposed of pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter (the "Merger Agreement") in exchange for a cash payment of $156.00 per share of common stock. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 20:10 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionRestricted Stock Units (11/11/2020) · Derivative | 825 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-011924 · marketforms-54275.xml · derivative · entry 4 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,586 Underlying: Common Stock · 825 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: RSUs were granted on November 11, 2020 and vested 34% on November 12, 2021; 33% will vest on November 12, 2022 and 33% will vest on November 12, 2023. RSUs will automatically be converted into shares of common stock on the date indicated and are entitled to dividend equivalent rights which accrue on dividend record dates. F4 · derivative.expiration_date: RSUs were granted on November 11, 2020 and vested 34% on November 12, 2021; 33% will vest on November 12, 2022 and 33% will vest on November 12, 2023. RSUs will automatically be converted into shares of common stock on the date indicated and are entitled to dividend equivalent rights which accrue on dividend record dates. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 20:10 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Tax withholdingCommon Stock | 242 | $155.11 | $37,536.62 |
DisclosureSEC source: 0001214659-21-011924 · marketforms-54275.xml · nonDerivative · entry 2 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,793 F2 · kind: Reflects the reporting person's payment of minimum statutory tax obligations by withholding shares of Hill-Rom Holdings, Inc. common stock incident to the vesting of RSUs in accordance with Rule 16b-3. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 20:10 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionCommon Stock | 825 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-21-011924 · marketforms-54275.xml · nonDerivative · entry 1 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 17:30 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | GrantRestricted Stock Units (11/10/2021) · Derivative | 7,032 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-011620 · marketforms-54243.xml · derivative · entry 1 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,032 Underlying: Common Stock · 7,032 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: RSUs vest 34% on November 11, 2022, 33% on November 11, 2023 and 33% on November 11, 2024. RSUs will automatically be converted into shares of common stock on the date indicated and are entitled to dividend equivalent rights which accrue on dividend record dates. F2 · derivative.expiration_date: RSUs vest 34% on November 11, 2022, 33% on November 11, 2023 and 33% on November 11, 2024. RSUs will automatically be converted into shares of common stock on the date indicated and are entitled to dividend equivalent rights which accrue on dividend record dates. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 20:57 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionRestricted Stock Units (11/06/2019) · Derivative | 483 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-011438 · marketforms-54211.xml · derivative · entry 7 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477.549 Underlying: Common Stock · 483 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: RSUs were granted on November 6, 2019 and vested 34% on November 7, 2020 and 33% on November 7, 2021; 33% will vest on November 7, 2022. RSUs will automatically be converted into shares of common stock on the date indicated and are entitled to dividend equivalent rights which accrue on dividend record dates. F5 · derivative.expiration_date: RSUs were granted on November 6, 2019 and vested 34% on November 7, 2020 and 33% on November 7, 2021; 33% will vest on November 7, 2022. RSUs will automatically be converted into shares of common stock on the date indicated and are entitled to dividend equivalent rights which accrue on dividend record dates. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 20:57 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionRestricted Stock Units (11/07/2018) · Derivative | 469 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-011438 · marketforms-54211.xml · derivative · entry 6 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 469 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: RSUs were granted on November 7, 2018 and vested 34% on November 8, 2019, 33% on November 8, 2020 and 33% on November 8, 2021. RSUs will automatically be converted into shares of common stock on the date indicated and are entitled to dividend equivalent rights which accrue on dividend record dates. F4 · derivative.expiration_date: RSUs were granted on November 7, 2018 and vested 34% on November 8, 2019, 33% on November 8, 2020 and 33% on November 8, 2021. RSUs will automatically be converted into shares of common stock on the date indicated and are entitled to dividend equivalent rights which accrue on dividend record dates. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 20:57 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Tax withholdingCommon Stock | 168 | $155.09 | $26,055.12 |
DisclosureSEC source: 0001214659-21-011438 · marketforms-54211.xml · nonDerivative · entry 4 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,210 F2 · kind: Reflects the reporting person's payment of minimum statutory tax obligations by withholding shares of Hill-Rom Holdings, Inc. common stock incident to the vesting of restricted stock units ("RSUs") in accordance with Rule 16b-3. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 20:57 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionCommon Stock | 483 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-21-011438 · marketforms-54211.xml · nonDerivative · entry 3 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,378 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: RSUs convert into common stock on a one-for-one basis. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 20:57 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Tax withholdingCommon Stock | 141 | $155.09 | $21,867.69 |
DisclosureSEC source: 0001214659-21-011438 · marketforms-54211.xml · nonDerivative · entry 2 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,895 F2 · kind: Reflects the reporting person's payment of minimum statutory tax obligations by withholding shares of Hill-Rom Holdings, Inc. common stock incident to the vesting of restricted stock units ("RSUs") in accordance with Rule 16b-3. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 20:57 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionCommon Stock | 469 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-21-011438 · marketforms-54211.xml · nonDerivative · entry 1 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: RSUs convert into common stock on a one-for-one basis. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 16:03 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | GrantEmployee Stock Option (11/11/2020) · Derivative | 9,513 | $0.00 Strike: $94.14 | $0.00 |
DisclosureSEC source: 0000047518-20-000142 · wf-form4_160530140000569.xml · derivative · entry 4 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,513 Underlying: Common Stock · 9,513 shares Expires 2030-11-11 F4 · derivative.exercise_date: Options vest 25% on each of November 11, 2021, 2022, 2023 and 2024. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 16:03 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | GrantRestricted Stock Units (11/11/2020) · Derivative | 2,411 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000047518-20-000142 · wf-form4_160530140000569.xml · derivative · entry 3 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,411 Underlying: Common Stock · 2,411 shares Expires 2023-11-12 F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: Restricted stock units vest 34% on November 12, 2021 and 33% on November 12, 2022 and 2023. Restricted stock units are entitled to dividend equivalent rights which accrue on dividend record dates. F3 · derivative.expiration_date: Restricted stock units vest 34% on November 12, 2021 and 33% on November 12, 2022 and 2023. Restricted stock units are entitled to dividend equivalent rights which accrue on dividend record dates. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 18:12 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionRestricted Stock Units (11/06/2019) · Derivative | 494 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000047518-20-000120 · wf-form4_160504992303163.xml · derivative · entry 10 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 960.549 Underlying: Common Stock · 494 shares Expires 2022-11-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F6 · derivative.exercise_date: Restricted stock units ("RSUs") were granted on November 6, 2019 and vested 34% on November 7, 2020; 33% will vest on November 7, 2021 and 2022, respectively. RSUs will automatically be converted into shares of common stock on the date indicated and are entitled to dividend equivalent rights which accrue on dividend record dates. F6 · derivative.expiration_date: Restricted stock units ("RSUs") were granted on November 6, 2019 and vested 34% on November 7, 2020; 33% will vest on November 7, 2021 and 2022, respectively. RSUs will automatically be converted into shares of common stock on the date indicated and are entitled to dividend equivalent rights which accrue on dividend record dates. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 18:12 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionRestricted Stock Units (11/7/2018) · Derivative | 462 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000047518-20-000120 · wf-form4_160504992303163.xml · derivative · entry 9 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464.39 Underlying: Common Stock · 462 shares Expires 2021-11-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: Restricted stock units ("RSUs") were granted on November 7, 2018 and vested 34% on November 8, 2019 and 33% on November 8, 2020. The remaining 33% will vest on November 8, 2021. RSUs will automatically be converted into shares of common stock on the date indicated and are entitled to dividend equivalent rights which accrue on dividend record dates. F5 · derivative.expiration_date: Restricted stock units ("RSUs") were granted on November 7, 2018 and vested 34% on November 8, 2019 and 33% on November 8, 2020. The remaining 33% will vest on November 8, 2021. RSUs will automatically be converted into shares of common stock on the date indicated and are entitled to dividend equivalent rights which accrue on dividend record dates. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 18:12 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionRestricted Stock Units (11/08/2017) · Derivative | 294 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000047518-20-000120 · wf-form4_160504992303163.xml · derivative · entry 8 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 294 shares Expires 2020-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: Restricted stock units ("RSUs") were granted on November 8, 2017 and vested 100% on November 9, 2020. RSUs will automatically be converted into shares of common stock on the date indicated and are entitled to dividend equivalent rights which accrue on dividend record dates. F4 · derivative.expiration_date: Restricted stock units ("RSUs") were granted on November 8, 2017 and vested 100% on November 9, 2020. RSUs will automatically be converted into shares of common stock on the date indicated and are entitled to dividend equivalent rights which accrue on dividend record dates. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 18:12 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Tax withholdingCommon Stock | 145 | $95.75 | $13,883.75 |
DisclosureSEC source: 0000047518-20-000120 · wf-form4_160504992303163.xml · nonDerivative · entry 6 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,567 F1 · kind: Reflects the reporting person's payment of minimum statutory tax obligations by withholding shares of Hill-Rom Holdings, Inc. Common Stock incident to the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 18:12 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionCommon Stock | 494 | $95.75 | $47,300.50 |
DisclosureSEC source: 0000047518-20-000120 · wf-form4_160504992303163.xml · nonDerivative · entry 5 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,712 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 18:12 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Tax withholdingCommon Stock | 136 | $95.75 | $13,022.00 |
DisclosureSEC source: 0000047518-20-000120 · wf-form4_160504992303163.xml · nonDerivative · entry 4 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,218 F1 · kind: Reflects the reporting person's payment of minimum statutory tax obligations by withholding shares of Hill-Rom Holdings, Inc. Common Stock incident to the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 18:12 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionCommon Stock | 462 | $95.75 | $44,236.50 |
DisclosureSEC source: 0000047518-20-000120 · wf-form4_160504992303163.xml · nonDerivative · entry 3 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,354 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 18:12 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Tax withholdingCommon Stock | 87 | $95.75 | $8,330.25 |
DisclosureSEC source: 0000047518-20-000120 · wf-form4_160504992303163.xml · nonDerivative · entry 2 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,892 F1 · kind: Reflects the reporting person's payment of minimum statutory tax obligations by withholding shares of Hill-Rom Holdings, Inc. Common Stock incident to the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 18:12 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionCommon Stock | 294 | $95.75 | $28,150.50 |
DisclosureSEC source: 0000047518-20-000120 · wf-form4_160504992303163.xml · nonDerivative · entry 1 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 16:32 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionPerformance Share Units (11/08/2017) · Derivative | 420 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000047518-20-000099 · wf-form4_160461183350792.xml · derivative · entry 4 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 420 shares Expires 2020-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · date: The shares of common stock were issued upon previously awarded performance based restricted stock. The performance based restricted stock unit award did not constitute derivative security reporting and therefore were not reported at the time of award. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 16:32 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Tax withholdingCommon Stock | 124 | $91.54 | $11,350.96 |
DisclosureSEC source: 0000047518-20-000099 · wf-form4_160461183350792.xml · nonDerivative · entry 2 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,685 F1 · kind: Reflects the reporting person's payment of minimum statutory tax obligations by withholding shares of Hill-Rom Holdings, Inc. Common Stock incident to the vesting of performance restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 16:32 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionCommon Stock | 420 | $91.54 | $38,446.80 |
DisclosureSEC source: 0000047518-20-000099 · wf-form4_160461183350792.xml · nonDerivative · entry 1 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,809 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2020 Filed Apr 9, 2020 16:03 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 905 | $0.00 Strike: $53.70 | $0.00 |
DisclosureSEC source: 0000047518-20-000046 · wf-form4_158646257092699.xml · derivative · entry 8 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302 Underlying: Common Stock · 905 shares Expires 2026-11-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vested or will vest 25% on each of November 14, 2017, 2018, 2019 and 2020. Read SEC document |
| April 07, 2020 Filed Apr 9, 2020 16:03 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 986 | $0.00 Strike: $46.28 | $0.00 |
DisclosureSEC source: 0000047518-20-000046 · wf-form4_158646257092699.xml · derivative · entry 7 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 986 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested 25% on each of February 22, 2017, 2018, 2019 and 2020. Read SEC document |
| April 07, 2020 Filed Apr 9, 2020 16:03 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | SaleCommon Stock | 905 | $110.00 | $99,550.00 |
DisclosureSEC source: 0000047518-20-000046 · wf-form4_158646257092699.xml · nonDerivative · entry 5 Dodrill Amy M. · CIK 0001778116 · President - Surgical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,389 F1 · kind: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.